Back to Rankings

OVID

Ovid TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-22
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
OVID vs peer average
71/100
OVID vs. peer average (B vs. C)
Grade spread
B 2 · C 3 · D 5
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

PRTA is the first available peer comparator.

Clinical-stage neurology biotech with event-driven valuation; useful as a loose comp for how pipeline timing and readout quality can drive sentiment in CNS names.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerPRTAProthena
OVID
Ovid Therapeutics
PRTA
Prothena
Grade
B
C
Momentum
93
16
Value
41
41
Sentiment
50
89
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Mixed

Grade position vs PRTA

OVID / PRTA
Grade Position
Above peers
OVID vs. peer average (B vs. C)
71/100
Momentum
93
OVID
Value
41
OVID
Sentiment
50
PRTA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs OVID
1
PRTA
PRTA
C
60/100
+1
2
RZLT
RZLT
D
40/100
+2
3
CCCC
CCCC
D
40/100
+2
4
CABA
Cabaletta Bio Inc Common
D
40/100
+2
5
QTTB
Q32 Bio Inc Common
D
40/100
+2
PRTA is the first peer returned for this comparison set.